Zantac® Heartburn Drug Lawsuit
Zantac® Medication Lawsuits and Settlements
FDA recalled this drug that may cause cancer.
ZANTAC® LAWSUIT INFORMATION
*On April 1, 2020 the U.S. Food and Drug Administration (FDA) requested that the heartburn drug Zantac® be pulled from the market immediately.
The FDA warned that Zantac® may be contaminated with the cancer-causing chemical NDMA (N-nitrosodimethylamine). Potential carcinogenic effects of NDMA exposure include, but are not limited to:
- Liver Cancer
- Kidney Cancer
- Stomach Cancer
- Colon Cancer
- Colorectal Cancer
- Prostate Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Bladder Cancer
- Other Digestive Tract Cancers
If you regularly used Zantac® and developed cancer, you may be entitled to significant financial compensation!
Do not stop taking your medication without first consulting with your physician. Doing so could result in injury or death.
If you or a loved one used Zantac® and suffered complications as a result, you could be owed money.
CALL NOW FOR A FREE CLAIM REVIEW at (800) 219-4019
Don’t wait, call now! You may be entitled to the financial compensation you deserve.
WHAT IS ZANTAC®:
Zantac® and its generic, ranitidine, are popular heartburn/antacid medications that have been on the market since the early 1980s. They belong to a group of drugs called histamine-2 blockers. Zantac® (ranitidine) works by reducing the amount of acid your stomach produces. It is mainly used to treat acid reflux and other conditions in which the stomach produces too much acid such as Zollinger-Ellison syndrome, gastroesophageal reflux disease (GERD), and other gastrointestinal issues. Zantac® and other generic versions of ranitidine are available over the counter (Zantac® OTC) and by prescription. Dosages vary between 75 and 150 mg tablets, though some patients take a once daily 300 mg dosage.
**In September 2019, Valisure, an online pharmacy based in Connecticut, informed the FDA that it had found the cancer-causing chemical N-nitrosodimethylamine (NDMA) in some batches of Zantac® and its generic, ranitidine.
Retailers including Walmart, Walgreens, CVS and Rite Aid pulled Zantac® and over-the-counter generics from their shelves.
NDMA is an industrial chemical used in gasoline, rocket fuel and other petroleum-based industrial products and is a known human carcinogen. NDMA levels in Zantac® may be 3,000 to 26,000 times higher than legally allowed levels set by the FDA.
Since the 1980s, numerous studies have demonstrated a link between the NDMA in Zantac® and cancer. Mounting evidence also allegedly shows that Sanofi and Boehringer Ingelheim, the big pharma companies that make Zantac® (ranitidine), concealed the Zantac® cancer link from millions of people who took the drug for heartburn, gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), sour stomach, Barrett’s esophagus, acid reflux and other issues. This deception came as the companies made unprecedented profits from Zantac®, the first drug to generate $1 billion in sales.